Literature DB >> 10441506

Identification and characterization of PKNbeta, a novel isoform of protein kinase PKN: expression and arachidonic acid dependency are different from those of PKNalpha.

K Oishi1, H Mukai, H Shibata, M Takahashi, Y Ona.   

Abstract

The cDNA clone encoding a novel isoform of protein kinase PKN, termed PKNbeta, was isolated from a HeLa cDNA library. PKNbeta had high sequence homology with PKNalpha, originally isolated PKN, especially in the repeats of charged amino acid-rich region with leucine-zipper like sequences (CZ region/HR1), in the carboxyl-terminal catalytic domain, and in approximately 130 amino acid stretch (D region/HR2), located between CZ region/HR1 and the catalytic domain. However, the amino acid sequence of PKNbeta differed from that of PKNalpha in the region immediately amino-terminal to the catalytic domain, which contained two distinct proline-rich sequences consistent with the class II consensus sequence, PXXPXR, for binding to SH3 domain. Distribution of PKNbeta differed from that of PKNalpha in the following two respects: (1) Northern blotting indicated that PKNbeta mRNA could not be detected in human adult tissues, but was expressed abundantly in human cancer cell lines; (2) immunochemical analysis indicated that PKNbeta localized in nucleus and perinuclear Golgi apparatus, and was almost absent in cytoplasmic region in NIH3T3 cells. Recombinant PKNbeta expressed in COS7 cells displayed autophosphorylation and peptide kinase activity, but was found to be significantly less responsive to arachidonic acid than PKNalpha. The identification of this novel isoform underscores the diversity of PKN signaling pathway. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10441506     DOI: 10.1006/bbrc.1999.1116

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  A Chemoproteomic Strategy for Direct and Proteome-Wide Covalent Inhibitor Target-Site Identification.

Authors:  Christopher M Browne; Baishan Jiang; Scott B Ficarro; Zainab M Doctor; Jared L Johnson; Joseph D Card; Sindhu Carmen Sivakumaren; William M Alexander; Tomer M Yaron; Charles J Murphy; Nicholas P Kwiatkowski; Tinghu Zhang; Lewis C Cantley; Nathanael S Gray; Jarrod A Marto
Journal:  J Am Chem Soc       Date:  2018-12-20       Impact factor: 15.419

2.  Hypotonic swelling-induced activation of PKN1 mediates cell survival in cardiac myocytes.

Authors:  Katsuya Kajimoto; Dan Shao; Hiromitsu Takagi; Gregorio Maceri; Daniela Zablocki; Hideyuki Mukai; Yoshitaka Ono; Junichi Sadoshima
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-29       Impact factor: 4.733

3.  The interaction of PKN3 with RhoC promotes malignant growth.

Authors:  Keziban Unsal-Kacmaz; Shoba Ragunathan; Edward Rosfjord; Stephen Dann; Erik Upeslacis; Mary Grillo; Richard Hernandez; Fiona Mack; Anke Klippel
Journal:  Mol Oncol       Date:  2011-12-28       Impact factor: 6.603

4.  Phosphorylation of protein kinase N by phosphoinositide-dependent protein kinase-1 mediates insulin signals to the actin cytoskeleton.

Authors:  L Q Dong; L R Landa; M J Wick; L Zhu; H Mukai; Y Ono; F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

5.  The SH2B1 obesity locus is associated with myocardial infarction in diabetic patients and with NO synthase activity in endothelial cells.

Authors:  Sabrina Prudente; Eleonora Morini; Jay Larmon; Francesco Andreozzi; Natalia Di Pietro; Angela Nigro; Ernest V Gervino; Gaia Chiara Mannino; Simonetta Bacci; Thomas H Hauser; Emanuele Bellacchio; Gloria Formoso; Fabio Pellegrini; Vittoria Proto; Claudia Menzaghi; Lucia Frittitta; Assunta Pandolfi; Giorgio Sesti; Alessandro Doria; Vincenzo Trischitta
Journal:  Atherosclerosis       Date:  2011-08-19       Impact factor: 5.162

6.  PKN3 is required for malignant prostate cell growth downstream of activated PI 3-kinase.

Authors:  Frauke Leenders; Kristin Möpert; Anett Schmiedeknecht; Ansgar Santel; Frank Czauderna; Manuela Aleku; Silke Penschuck; Sibylle Dames; Maria Sternberger; Thomas Röhl; Axel Wellmann; Wolfgang Arnold; Klaus Giese; Jörg Kaufmann; Anke Klippel
Journal:  EMBO J       Date:  2004-07-29       Impact factor: 11.598

7.  A novel inducible transactivation domain in the androgen receptor: implications for PRK in prostate cancer.

Authors:  Eric Metzger; Judith M Müller; Stefano Ferrari; Reinhard Buettner; Roland Schüle
Journal:  EMBO J       Date:  2003-01-15       Impact factor: 11.598

8.  A rho-binding protein kinase C-like activity is required for the function of protein kinase N in Drosophila development.

Authors:  Martha Betson; Jeffrey Settleman
Journal:  Genetics       Date:  2007-05-16       Impact factor: 4.562

9.  Regulatory domain selectivity in the cell-type specific PKN-dependence of cell migration.

Authors:  Sylvie Lachmann; Amy Jevons; Manu De Rycker; Adele Casamassima; Simone Radtke; Alejandra Collazos; Peter J Parker
Journal:  PLoS One       Date:  2011-07-06       Impact factor: 3.240

10.  RMD-1, a novel microtubule-associated protein, functions in chromosome segregation in Caenorhabditis elegans.

Authors:  Kumiko Oishi; Hideyuki Okano; Hitoshi Sawa
Journal:  J Cell Biol       Date:  2007-12-10       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.